{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:40:45Z","timestamp":1792366845460,"version":"4.4.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1097\/md.0000000000009935","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T20:51:13Z","timestamp":1520369473000},"page":"e9935","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of a new matrix regenerating agent in patients with Sj\u00f6gren syndrome and superficial ulcerative keratitis resistant to conventional therapy"],"prefix":"10.1097","volume":"97","author":[{"given":"Franck","family":"Fajnkuchen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Barritault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Giocanti-Aur\u00e9gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-46-20210226","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2013-203845","article-title":"Comparison of the American\u2013European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort","volume":"73","author":"Rasmussen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R2-46-20210226","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/bjophthalmol-2012-301767","article-title":"Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye","volume":"96","author":"Liew","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R3-46-20210226","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajo.2007.03.055","article-title":"Tear evaporation rates in Sj\u00f6gren syndrome and non-Sj\u00f6gren dry eye patients","volume":"144","author":"Goto","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R4-46-20210226","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/archopht.121.10.1364","article-title":"Evaluation of the clinical course of dry eye syndrome","volume":"121","author":"Horwath-Winter","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R5-46-20210226","first-page":"25","article-title":"Treating the nonhealing epithelial defect","volume":"6","author":"Jeng","year":"2011","journal-title":"Cataract Refract Surg Today Europe"},{"key":"R6-46-20210226","first-page":"457","article-title":"The healing of alkali-injured cornea is stimulated by a novel matrix regenerating agent (RGTA, CACICOL20): a biopolymer mimicking heparan sulfates reducing proteolytic, oxidative and nitrosative damage","volume":"29","author":"Cejkova","year":"2014","journal-title":"Histol Histopathol"},{"key":"R7-46-20210226","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1167\/iovs.12-10476","article-title":"Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers","volume":"53","author":"Aifa","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-46-20210226","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R9-46-20210226","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"R10-46-20210226","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R11-46-20210226","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/ICO.0b013e3181a16472","article-title":"High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen","volume":"28","author":"Dastjerdi","year":"2009","journal-title":"Cornea"},{"key":"R12-46-20210226","first-page":"CD009327","article-title":"Autologous serum eye drops for dry eye","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-46-20210226","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/ICO.0000000000000169","article-title":"Combined topical application of a regenerative agent with a bandage contact lens for the treatment of persistent epithelial defects","volume":"33","author":"Kymionis","year":"2014","journal-title":"Cornea"},{"key":"R14-46-20210226","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jfo.2013.01.012","article-title":"RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies","volume":"36","author":"Brignole-Baudouin","year":"2013","journal-title":"J Fr Ophtalmol"},{"key":"R15-46-20210226","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10719-016-9744-5","article-title":"RGTA(\u00ae) or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients","volume":"34","author":"Barritault","year":"2017","journal-title":"Glycoconj J"},{"key":"R16-46-20210226","first-page":"465","article-title":"Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy","volume":"31","author":"Chebbi","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"R17-46-20210226","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jbm.a.30723","article-title":"Heparin-like synthetic polymers, named RGTAs, mimic biological effects of heparin in vitro","volume":"78","author":"Rouet","year":"2006","journal-title":"J Biomed Mater Res A"},{"key":"R18-46-20210226","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11882-013-0403-7","article-title":"Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca","volume":"14","author":"Liu","year":"2014","journal-title":"Curr Allergy Asthma Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:57:05Z","timestamp":1620961025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201803090-00046"}},"subtitle":["A report of 3 cases"],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009935","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}